Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Allarity Therapeutics Inc (ALLR)

Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Allarity Therapeutics Inc 24 SCHOOL ST. 2ND FLOOR BOSTON MA 02108 USA

www.allarity.com Employees: 6 P: 401-426-4664

Description:

Allarity Therapeutics Inc. is a clinical-stage biopharmaceutical company. It involved in developing novel oncology therapeutics together with drug-specific DRP(R) companion diagnostics for personalized cancer care. Allarity Therapeutics Inc. is based in Cambridge, MA U.S.A.

Key Statistics

Overview:

Market Capitalization, $K 4,390
Enterprise Value, $K 5,960
Shares Outstanding, K 4,434
Annual Sales, $ 0 K
Annual Net Income, $ -11,900 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -11,590 K
EBIT, $ -15,110 K
EBITDA, $ -15,070 K
60-Month Beta 0.35
% of Insider Shareholders 0.08%
% of Institutional Shareholders 11.53%
Float, K 4,430
% Float 99.92%
Short Volume Ratio 0.50

Growth:

1-Year Return -99.71%
3-Year Return -100.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -7.71 on 11/14/24
Next Earnings Date 11/12/24
Earnings Per Share ttm -675.88
EPS Growth vs. Prev Qtr -133.40%
EPS Growth vs. Prev Year 99.43%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 09/11/24

ALLR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -369.67%
Return-on-Assets % -100.06%
Profit Margin % 0.00%
Debt/Equity 0.10
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.22
Book Value/Share 4.70
Interest Coverage -22.64
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar